Page 134 - Haematologica May 2022

S. Napoli et al.
wrote the manuscript; SN and FB conceived and supervised the study, and extensively reviewed the manuscript; LC performed data mining; AR performed next generation sequencing; AAM reviewed the manuscript; FS, FG, FZ, GS performed experi- ments; MF, SB provided bioinformatic support; MTC, AC, PG
and GI provided clinical samples data; OE and GI provided transcriptome data. All authors read and edited the manuscript.
Funding
Partially supported by funds from Gelu Foundation (to BF).
References
1. Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320- 334.
2. Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307-319.
3. Zhang J, Vlasevska S, Wells VA, et al. The CREBBP acetyltransferase is a haploinsuffi- cient tumor suppressor in B-cell lymphoma. Cancer Discov. 2017;7(3):322-337.
4. Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activi- ty-regulated enhancers. Nature. 2010;465 (7295):182-187.
5. Arnold PR, Wells AD, Li XC. Diversity and emerging roles of enhancer RNA in regula- tion of gene expression and cell fate. Front Cell Dev Biol. 2019;7:377.
6. Li W, Notani D, Rosenfeld MG. Enhancers as non-coding RNA transcription units: recent insights and future perspectives. Nat Rev Genet. 2016;17(4):207-223.
7. Liu F. Enhancer-derived RNA: a primer. Genomics Proteomics Bioinformatics. 2017;15(3):196-200.
8. Jiao W, Chen Y, Song H, et al. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and reg- ulating hnRNPU/p300/EGR1/HPSE axis. Oncogene. 2018;37(20):2728-2745.
9. Li W, Notani D, Ma Q, et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature. 2013;498 (7455):516-520.
10.Fanucchi S, Shibayama Y, Burd S, et al. Chromosomal contact permits transcription between coregulated genes. Cell. 2013;155 (3):606-620.
11. Tan SH, Leong WZ, Ngoc PCT, et al. The enhancer RNA ARIEL activates the onco- genic transcriptional program in T-cell acute lymphoblastic leukemia. Blood. 2019;134 (3):239-251.
12. Marques AC, Hughes J, Graham B, et al. Chromatin signatures at transcriptional start sites separate two equally populated yet dis- tinct classes of intergenic long noncoding RNAs. Genome Biol. 2013;14(11):R131.
13. Alvarez-Dominguez JR, Knoll M, Gromatzky AA, et al. The super-enhancer- derived alncRNA-EC7/Bloodlinc potentiates red blood cell development in trans. Cell Rep. 2017;19(12):2503-2514.
14.Agirre X, Meydan C, Jiang Y, et al. Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response. Nat Commun. 2019;10(1):821.
15. Verma A, Jiang Y, Du W, et al. Transcriptome sequencing reveals thou- sands of novel long non-coding RNAs in B cell lymphoma. Genome Med. 2015;7:110.
16. Mlynarczyk C, Fontan L, Melnick A. Germinal center-derived lymphomas: the darkest side of humoral immunity. Immunol Rev. 2019;288(1):214-239.
17. Pasqualucci L, Dalla-Favera R. Genetics of diffuse large B-cell lymphoma. Blood. 2018;131(21):2307-2319.
18. Wright GW, Huang DW, Phelan JD, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37(4):551-568.
19.Chapuy B, Stewart C, Dunford AJ, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct path- ogenic mechanisms and outcomes. Nat Med. 2018;24(5):679-690.
20.Ceribelli M, Kelly PN, Shaffer AL, et al. Blockade of oncogenic IkappaB kinase activ- ity in diffuse large B-cell lymphoma by bro- modomain and extraterminal domain pro- tein inhibitors. Proc Natl Acad Sci U S A. 2014;111(31):11365-11370.
21. Reddy A, Zhang J, Davis NS, et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017;171(2):481-494.
22. Teitell MA. OCA-B regulation of B-cell development and function. Trends Immunol. 2003;24(10):546-553.
23. Chapuy B, McKeown MR, Lin CY, et al. Discovery and characterization of super- enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell. 2013;24(6):777-790.
24.Gaudio E, Tarantelli C, Spriano F, et al. Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models. Haematologica. 2020;105(11):2584- 2591.
25. Napoli S, Piccinelli V, Mapelli SN, et al. Natural antisense transcripts drive a regula- tory cascade controlling c-MYC transcrip- tion. RNA Biol. 2017;14(12):1742-1755.
26. Vance KW. Mapping long noncoding RNA chromatin occupancy using capture hybridization analysis of RNA targets (CHART). Methods Mol Biol. 2017;1468:39- 50.
27. Sexton AN, Machyna M, Simon MD. Capture hybridization analysis of DNA tar- gets. Methods Mol Biol. 2016;1480:87-97.
28. Kharchenko PV, Tolstorukov MY, Park PJ. Design and analysis of ChIP-seq experi- ments for DNA-binding proteins. Nat Biotechnol. 2008;26(12):1351-1359.
29.Zhang Y, Liu T, Meyer CA, et al. Model- based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9(9):R137.
30. Vance KW, Sansom SN, Lee S, et al. The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J. 2014;33(4):296-311.
31. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57-74.
32. Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activi- ty. Cell. 2015;161(4):774-789.
33. Teater M, Dominguez PM, Redmond D, et al. AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lym- phomagenesis. Nat Commun. 2018;9(1): 222.
34. Poretti G, Kwee I, Bernasconi B, et al. Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines [Research Support, Non-U.S. Gov't]. Leuk Res. 2011;35(6):808- 813.
35. Auer RL, Starczynski J, McElwaine S, et al. Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2005;43(1):1- 10.
36. Zhao C, Inoue J, Imoto I, et al. POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by direct- ly regulating expression of a B-cell matura- tion factor, TNFRSF17. Oncogene. 2008;27(1):63-75.
37. Chigrinova E, Rinaldi A, Kwee I, et al. Two main genetic pathways lead to the transfor- mation of chronic lymphocytic leukemia to Richter syndrome. Blood. 2013;122(15): 2673-2682.
38. Boi M, Rinaldi A, Kwee I, et al. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood. 2013;122(15):2683-2693.
39.Martinez N, Almaraz C, Vaque JP, et al. Whole-exome sequencing in splenic margin- al zone lymphoma reveals mutations in genes involved in marginal zone differentia- tion. Leukemia. 2014;28(6):1334-1340.
40. Rinaldi A, Kwee I, Young KH, et al. Genome-wide high resolution DNA profil- ing of hairy cell leukaemia. Br J Haematol. 2013;162(4):566-569.
41. Rossi D, Trifonov V, Fangazio M, et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012;209(9):1537- 1551.
42. De Silva NS, Klein U. Dynamics of B cells in germinal centres. Nat Rev Immunol. 2015;15(3):137-148.
43. Brazao TF, Johnson JS, Muller J, et al. Long noncoding RNAs in B-cell development and activation. Blood. 2016;128(7):e10-19.
44. Tarantelli C, Gaudio E, Arribas AJ, et al. PQR309 is a novel dual PI3K/mTOR inhibitor with preclinical antitumor activity in lymphomas as a single agent and in com- bination therapy. Clin Cancer Res. 2018;24 (1):120-129.
45. Ma B, Hottiger MO. Crosstalk between Wnt/beta-Catenin and NF-kappaB signaling pathway during inflammation. Front Immunol. 2016;7:378.
46. Guo X, Wang XF. Signaling cross-talk between TGF-beta/BMP and other path- ways. Cell Res. 2009;19(1):71-88.
47. Grumolato L, Liu G, Haremaki T, et al. beta- Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 tran- scription factors. PLoS Genet. 2013;9(8): e1003603.
48. Daniels DL, Weis WI. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activa- tion. Nat Struct Mol Biol. 2005;12(4):364-371.
1142
haematologica | 2022; 107(5)